cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Ricko Dharmadi Utama
Contact Email
apinaga53@gmail.com
Phone
+6282256602225
Journal Mail Official
editormltj@gmail.com
Editorial Address
Jl. H. Mistar Cokrokusumo No.1A, Kemuning, Kec. Banjarbaru Selatan, Kota Banjar Baru, Kalimantan Selatan 70714
Location
Kota banjarmasin,
Kalimantan selatan
INDONESIA
Medical Laboratory Technology Journal
Published by Poltekkes Kemenkes Banjarmasin
ISSN : -     EISSN : 24610879     DOI : https://doi.org/10.31964/mltj
Core Subject : Health, Science,
Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Nursing Public Health
The aim of this journal publication is to disseminate the conceptual thoughts or ideas and research results that have achieved in the area of medical laboratory sciences. This Journal particularly focuses on the main problems in the development of the sciences of medical laboratory areas. It covers the parasitology, bacteriology, virology, hematology, clinical chemistry, toxicology, food and drink chemistry, and any sciences that cover sciences of medical laboratory area.
Arjuna Subject : Imunologi dan Mikrobiologi (semua kategori) - Mikrobiologi dan Bioteknologi Terapan
Articles 11 Documents
 1   2 
Search results for , issue "Vol. 7 No. 1 (2021): June" : 11 Documents clear
New Candidate Predisposition Genes for Hereditary Breast Cancer: SLIT3, CREB3, USP39 Kirill Zagorodnev; Alexandr Romanko; Anna P. Sokolenko; Ilya Bizin; Ekaterina S. Kuligina
Medical Laboratory Technology Journal Vol. 7 No. 1 (2021): June
Publisher : Poltekkes Kemenkes Banjarmasin Jurusan Analis Kesehatan

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (292.528 KB) | DOI: 10.31964/mltj.v7i1.401

Abstract

Breast cancer is the most common type of malignant neoplasm in women. BRCA1 and BRCA2 are the most commonly mutated genes, but only up to 30% of hereditary breast cancer cases are attributed to alterations in these genes. A large proportion of genetic causes of hereditary breast cancer remains unknown. Thus, the search for new hereditary mutations and establishing a genetic alteration in each case of hereditary breast cancer is a clinically significant task; be the goal of our research. Next-generation sequencing (NGS) allows for simultaneous analysis of hundreds to thousands of genes at one time. We analyzed the genetic material of 49 patients of the northwest Russian population with clinical signs of hereditary breast cancer and identified new mutations associated with hereditary breast cancer. Research results show two missense mutations - SLIT3 p.Arg154Cys, CREB3 p.Lys157Glu, and truncating mutation - USP39 c.*208G>C. Research conclusion; The identified mutations can explain only a tiny fraction of hereditary breast cancer cases (0.7% to 1.1%). The next step to increase the practical value of the detected alterations should be the analysis of biological characteristics of tumors in carriers of these mutations that can potentially become a target for chemotherapy.

Page 2 of 2 | Total Record : 11

 1   2 

Filter by Year

2021 2021


Reset
Filter By Issues
All Issue Vol. 11 No. 2 (2025): December Vol. 11 No. 1 (2025): June Vol. 10 No. 2 (2024): December Vol. 10 No. 1 (2024): June Vol. 9 No. 2 (2023): December Vol. 9 No. 1 (2023): June Vol. 8 No. 2 (2022): December Vol. 8 No. 1 (2022): June Vol. 7 No. 2 (2021): December Vol. 7 No. 1 (2021): June Vol. 6 No. 2 (2020): December Vol. 6 No. 1 (2020): June Vol. 5 No. 2 (2019): December Vol. 5 No. 1 (2019): June Vol. 4 No. 2 (2018): December Vol. 4 No. 1 (2018): June Vol. 3 No. 2 (2017): December Vol. 3 No. 1 (2017): June Vol. 2 No. 2 (2016): December Vol. 2 No. 1 (2016): June Vol. 1 No. 2 (2015): December Vol. 1 No. 1 (2015): June More Issue